Focused Cardiac Ultrasound in Surgery

Surgery Clinical Trial

— PreOPFOCUS  

Official title:

The Effects of Pre-operative Point-of-Care Focused Cardiac Ultrasound on Patient Outcome - a Prospective, Randomized, Clinical Study (PreOPFOCUS)

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT03501927
• Other study ID #: PreOPFOCUS
• Status: Terminated
• Phase: N/A
• Start date: May 7, 2018
• Est. completion date: September 1, 2020

Study information

• Verified date: April 2021
• Source: University of Aarhus
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Mortality and morbidity remain high after non-cardiac surgery. Known risk factors include age, high ASA grade and emergency surgery. Point-of-care focused cardiac ultrasound may elucidate pathology and potential hemodynamic compromise unknown to handling physicians. This study aims to investigate the effects of focused cardiac ultrasound in high-risk patients undergoing non-cardiac surgery with respect to clinical endpoints.

Description:

In non-cardiac surgery major risk factors for morbidity and mortality include ASA classification, age, acute surgery and pre-existing cardiopulmonary disease. These risk factors are sometimes readily available and, along with the type of surgery, allow anaesthesiologists to tailor anaesthetic drugs, fluid therapy and monitoring to the individual patient need. However, cardiopulmonary disease may be occult or masked by other patient-related incapacities. Hence, identification of cardiopulmonary disease is an important priority during the pre-operative anaesthesia evaluation. Routine pre-operative anaesthesia evaluation includes screening with auscultation, blood tests and often electrocardiography. However, these exams are insensitive for detecting cardiopulmonary diseases that may be life threatening during anaesthesia, including ischaemia, heart valve disease and left ventricular hypertrophy. Point-of-care focused cardiac ultrasound (FOCUS) is claimed to be an effective method for filling out this obvious gap in rapid diagnostic capability, as FOCUS can detect both structural and functional cardiac disease as well as pleural effusion. FOCUS performed by anaesthesiologists can identify unknown pathologies in surgical patients and identification of these enables prediction of perioperative morbidity. Although pre-operative FOCUS has been shown to alter anaesthetic patient management, it remains unclear whether the application of FOCUS actually impacts patient outcome. This study aims to clarify whether pre-operative FOCUS changes clinical outcomes in high-risk patients undergoing acute, non-cardiac surgery. The hypothesis of the study is that pre-operative FOCUS reduces the fraction of patients admitted to hospital for more than 10 days or are dead within 30 days after high risk, non-cardiac surgery.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 337
• Est. completion date: September 1, 2020
• Est. primary completion date: September 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Patients scheduled for emergency (< 6 hours) or urgent surgery (< 24 hours)15
• General or neuro-axial anaesthesia planned at the first anesthetic visit
• ASA classification 3 or 4.
• Age = 65 years

Exclusion Criteria:

• Previous surgery performed during current hospital admission (including transfers from other hospitals than Randers Regional Hospital/Hospital of Southern Jutland)
• Low risk surgery or expected surgery time < 30 minutes or endoscopies.
• Lack of consent from patient or proxy (in case of patient mental incapacity)
• Previous participation in the study. Pre-operative FOCUS not possible for logistical reasons or due to requirement for immediate surgery Drop-out Criteria: Patients who refuse participation after formal inclusion will drop out.
• Patients converted from a primary anaesthetic plan of general/neuro-axial anaesthesia to regional anaesthesia will not drop-out. -

Related Conditions & MeSH terms

• Cardiopulmonary Disease
• Complication
• Morality
• Pulmonary Heart Disease
• Surgery

Intervention

Diagnostic Test:
• FOCUS (focused cardiac ultrasound)
A ultrasound of the heart and pleura will be performed. This provide information on Left ventricular systolic function Left ventricular diastolic function Right ventricular systolic function Right ventricular pressure overload Biventricular sizes Pathology of the mitral- and aortic valves Pericardial fluid Gross fluid status Pleural effusion

Locations

Country	Name	City	State
Denmark	Department of Anaesthesiology	Randers

Sponsors (3)

Lead Sponsor	Collaborator
Aarhus University Hospital	Aabenraa Hospital, Randers Regional Hospital

Country where clinical trial is conducted

Denmark, 

References & Publications (26)

Asch FM, Shah S, Rattin C, Swaminathan S, Fuisz A, Lindsay J. Lack of sensitivity of the electrocardiogram for detection of old myocardial infarction: a cardiac magnetic resonance imaging study. Am Heart J. 2006 Oct;152(4):742-8. — View Citation

Balik M, Plasil P, Waldauf P, Pazout J, Fric M, Otahal M, Pachl J. Ultrasound estimation of volume of pleural fluid in mechanically ventilated patients. Intensive Care Med. 2006 Feb;32(2):318. doi: 10.1007/s00134-005-0024-2. Epub 2006 Jan 24. — View Citation

Beyerbacht HP, Bax JJ, Lamb HJ, van der Laarse A, Vliegen HW, de Roos A, Zwinderman AH, van der Wall EE. Evaluation of ECG criteria for left ventricular hypertrophy before and after aortic valve replacement using magnetic resonance imaging. J Cardiovasc Magn Reson. 2003 Jul;5(3):465-74. — View Citation

Bilimoria KY, Liu Y, Paruch JL, Zhou L, Kmiecik TE, Ko CY, Cohen ME. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013 Nov;217(5):833-42.e1-3. doi: 10.1016/j.jamcollsurg.2013.07.385. Epub 2013 Sep 18. — View Citation

Bøtker MT, Vang ML, Grøfte T, Sloth E, Frederiksen CA. Routine pre-operative focused ultrasonography by anesthesiologists in patients undergoing urgent surgical procedures. Acta Anaesthesiol Scand. 2014 Aug;58(7):807-14. doi: 10.1111/aas.12343. Epub 2014 May 28. — View Citation

Canty DJ, Royse CF, Kilpatrick D, Williams DL, Royse AG. The impact of pre-operative focused transthoracic echocardiography in emergency non-cardiac surgery patients with known or risk of cardiac disease. Anaesthesia. 2012 Jul;67(7):714-20. doi: 10.1111/j.1365-2044.2012.07118.x. Epub 2012 Mar 27. — View Citation

Cowie B. Focused transthoracic echocardiography predicts perioperative cardiovascular morbidity. J Cardiothorac Vasc Anesth. 2012 Dec;26(6):989-93. doi: 10.1053/j.jvca.2012.06.031. Epub 2012 Aug 22. — View Citation

Davenport DL, Ferraris VA, Hosokawa P, Henderson WG, Khuri SF, Mentzer RM Jr. Multivariable predictors of postoperative cardiac adverse events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007 Jun;204(6):1199-210. — View Citation

Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN; American College of Cardiology; American Heart Association. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014 Dec 9;64(22):e77-137. doi: 10.1016/j.jacc.2014.07.944. Epub 2014 Aug 1. — View Citation

Glance LG, Lustik SJ, Hannan EL, Osler TM, Mukamel DB, Qian F, Dick AW. The Surgical Mortality Probability Model: derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann Surg. 2012 Apr;255(4):696-702. doi: 10.1097/SLA.0b013e31824b45af. — View Citation

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30. — View Citation

Holm JH, Frederiksen CA, Juhl-Olsen P, Sloth E. Perioperative use of focus assessed transthoracic echocardiography (FATE). Anesth Analg. 2012 Nov;115(5):1029-32. doi: 10.1213/ANE.0b013e31826dd867. Epub 2012 Oct 9. Review. — View Citation

Kheterpal S, O'Reilly M, Englesbe MJ, Rosenberg AL, Shanks AM, Zhang L, Rothman ED, Campbell DA, Tremper KK. Preoperative and intraoperative predictors of cardiac adverse events after general, vascular, and urological surgery. Anesthesiology. 2009 Jan;110(1):58-66. doi: 10.1097/ALN.0b013e318190b6dc. — View Citation

Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ; Participants in the VA National Surgical Quality Improvement Program. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005 Sep;242(3):326-41; discussion 341-3. — View Citation

Kratz T, Campo Dell'Orto M, Exner M, Timmesfeld N, Zoremba M, Wulf H, Steinfeldt T. Focused intraoperative transthoracic echocardiography by anesthesiologists: a feasibility study. Minerva Anestesiol. 2015 May;81(5):490-6. Epub 2014 Sep 15. — View Citation

Kratz T, Steinfeldt T, Exner M, Dell Orto MC, Timmesfeld N, Kratz C, Skrodzki M, Wulf H, Zoremba M. Impact of Focused Intraoperative Transthoracic Echocardiography by Anesthesiologists on Management in Hemodynamically Unstable High-Risk Noncardiac Surgery Patients. J Cardiothorac Vasc Anesth. 2017 Apr;31(2):602-609. doi: 10.1053/j.jvca.2016.11.002. Epub 2016 Nov 2. — View Citation

Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, Hert SD, Ford I, Gonzalez-Juanatey JR, Gorenek B, Heyndrickx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Lüscher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Sousa-Uva M, Voudris V, Funck-Brentano C; Authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014 Sep 14;35(35):2383-431. doi: 10.1093/eurheartj/ehu282. Epub 2014 Aug 1. — View Citation

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003. — View Citation

Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005 Jun;67(6):2089-100. — View Citation

M Saklad. Grading patients for surgical procedures. Anesthesiology 1941;2:281-4

Moore CL. Does Ultrasound Improve Clinical Outcomes? Prove It. Crit Care Med. 2015 Dec;43(12):2682-3. doi: 10.1097/CCM.0000000000001325. — View Citation

Olive KE, Grassman ED. Mitral valve prolapse: comparison of diagnosis by physical examination and echocardiography. South Med J. 1990 Nov;83(11):1266-9. — View Citation

Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8. doi: 10.1016/j.echo.2010.05.010. — View Citation

Ryan T, Petrovic O, Dillon JC, Feigenbaum H, Conley MJ, Armstrong WF. An echocardiographic index for separation of right ventricular volume and pressure overload. J Am Coll Cardiol. 1985 Apr;5(4):918-27. — View Citation

Section 2: AKI Definition. Kidney Int Suppl (2011). 2012 Mar;2(1):19-36. — View Citation

Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002 Dec 15;90(12):1284-9. — View Citation

* Note: There are 26 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of patients admitted to hospital = 10 days or dead within 30 days		30 days after surgery
Secondary	Length of stay	Defined as the number of days admitted to hospital from the date of surgery (included)	Up to 180 days after surgery
Secondary	Re-admissions to hospital	Re-admissions to hospital (no) within 90 days (no)	Up to 90 days after surgery
Secondary	Length of stay	Length of stay including re-admissions to hospital within 90 days	Up to 90 days after surgery
Secondary	Death = 30 days & = 90 days	Death = 30 days & = 90 days (no)	Up to 90 days after surgery
Secondary	Intensive care treatment	Intensive care treatment (hours)	Up to 90 days after surgery
Secondary	Postoperative ventilator treatment	Postoperative ventilator treatment (hours)	Up to 90 days after surgery
Secondary	Admittance to the post-operative care unit	Admittance to the post-operative care unit (hours)	Up to 1 day after surgery
Secondary	Development of acute kidney injury	Development of acute kidney injury (AKI) (stage 1,2 & 3, defined by th KDIGO creatinine criteria within seven days of surgery)	Within 7 days of surgery
Secondary	Accumulated intra- and postoperative infusion of norepinephrine, epinephrine, phenylephrine, ephedrine, dobutamine, dopamine and other vasoactive drugs.	Accumulated intra- and postoperative infusion of norepinephrine, epinephrine, phenylephrine, ephedrine, dobutamine, dopamine and other vasoactive drugs (mg).	From start of anaesthesia til end of anaesthesia
Secondary	Accumulated fluid balance	Accumulated fluid balance until end of surgery	From start of anaesthesia til end of anaesthesia
Secondary	Echocardiography	Formal echocardiography's (1) ordered and (2) actually performed in total and secondarily due to preoperative FOCUS (no).	From anaeshetic visit to start of anaesthesia
Secondary	Surgery cancellations due to preoperative FOCUS	Surgery cancellations in total and secondarily due to preoperative FOCUS (no)	Before start of anaeshesia
Secondary	Surgery postponements due to preoperative FOCUS	Surgery postponements in total and secondarily due to preoperative FOCUS (no).	Within 7 days of preoperative anaesthetic visit
Secondary	Surgery changes	Surgery changes in total and secondarily due to preoperative FOCUS (no, type).	From FOCUS to the start of surgery
Secondary	Perioperative myocardial damage	Troponin I	From the day before surgery to the day following surgery
Secondary	Changes in anesthetic practice	Changes in anesthetic practice/perianesthetic care DUE to preoperative FOCUS. Includes both step up/step down	From start of anaesthesia to start of surgery
Secondary	Echocardiography	Formal echocardiographies ordered prior to surgery	From FOCUS to start of surgery
Secondary	Volume	Volume infusion prior to anesthesia. Both in total and facilitated by FOCUS	From FOCUS to the start of anaesthesia
Secondary	Anaesthesia type	Conversion of Anaesthesia type from primary anesthetic visit to actually performed. Both in total and facilitated by FOCUS.	From FOCUS to the start of anaesthesia
Secondary	Anaesthetic monitoring	Step up and step down in anesthetic monitoring. Both in total and facilitated by FOCUS. Includes extra intravenous lines inserted including central venous catheters, arterial lines inserted, change to 5-lead ECG, vasopressors infused with anaesthetic induction	From start of anaesthesia to end of anaesthesia
Secondary	Anesthesia time	Anesthesia time	From start of anaesthesia to end of anaesthesia
Secondary	Surgery time	Surgery time	From start of surgery to end of surgery
Secondary	Cardiogenic pulmonary oedema	Cardiogenic pulmonary oedema within 30 days of surgery	From start of anaesthesia to 30 days after surgery
Secondary	New onset cardiac arrhythmia	New onset cardiac arrhythmia of any kind.	From start of anaesthesia to 30 days after surgery
Secondary	Non-fatal cardiac arrest	Non-fatal cardiac arrest regardless of cause.	From start of anaesthesia to 30 days after surgery
Secondary	Anastomotic breakdown	Anastomotic breakdown (deep or superficial)	From start of anaesthesia to 30 days after surgery
Secondary	Myocardial infarction	Myocardial infarction as defined by the universal criteria	From start of anaesthesia to 30 days after surgery
Secondary	Stroke	Cerebral stroke	From start of anaesthesia to 30 days after surgery
Secondary	Pulmonary embolism	Pulmonary embolism with radiological confirmation	From start of anaesthesia to 30 days after surgery
Secondary	Postoperative haemorrhage	Postoperative haemorrhage demanding blood transfusion	From end of anaesthesia to 30 days after surgery
Secondary	Gastrointestinal bleed	Gastrointestinal bleed	From start of anaesthesia to 30 days after surgery
Secondary	Pneumonia	Pneumonia	From start of anaesthesia to 30 days after surgery
Secondary	Surgical site infection	Surgical site infection (superficial or deep)	From end of anaesthesia to 30 days after surgery
Secondary	Urinary tract infection	Urinary tract infection	From end of anaesthesia to 30 days after surgery
Secondary	Infektion, source unknown	Infektion, source unknown.	From end of anaesthesia to 30 days after surgery